Insmed Incorporated (INSM) posted a fourth-quarter net loss of $186.1 million, or $1.28 per share, compared to a net loss of $160.1 million, or $1.21 per share, for the fourth-quarter 2022. On average, 12 analysts polled by Thomson Reuters expected the company to report a loss per share of $1.15, for the quarter. Analysts' estimates typically exclude special items.
Fourth quarter total revenue was $83.7 million, reflecting 41% growth compared to total revenue of $59.3 million for the fourth quarter of 2022. Analysts on average had estimated $82.76 million in revenue.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.